- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.79 Amendment No. 2 to the Lease Agreement for the Company's Facilities In Irvine
- 10.80 Form of Incentive/nonqualified Stock Option Agreement
- 10.81 Form of Restricted Stock Award
- 10.82 Amendment to the Employment Agreemented Dated May 17, 2000 - James H. Coleman
- 10.83 Amendment to the Employment Agreement Dated June 5, 1995 - Gary A. Rogers, PH.D.
- 23.1 Consent of Ernst & Young LLP
- 31.1 Section 302 Certification by Chief Executive Officer
- 31.2 Section 302 Certification by Chief Financial Officer
- 32 Section 906 Certification of CEO and CFO
EXHIBIT 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-108948 and No. 333-112043) of Cortex Pharmaceuticals, Inc. and in the related Prospectus and in the Registration Statements (Form S-8 No. 333-102042, No. 333-82477 and No. 333-20777) pertaining to the 1996 Stock Incentive Plan, the 1989 Incentive Stock Option, Nonqualified Stock Option and Stock Purchase Plan, the 1989 Special Nonqualified Stock Option and Stock Purchase Plan, and the Executive Stock Plan, of Cortex Pharmaceuticals, Inc. of our report dated July 27, 2004, with respect to the financial statements of Cortex Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended June 30, 2004.
/s/ Ernst & Young LLP
San Diego, California
September 22, 2004